<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="other"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Ayu</journal-id><journal-id journal-id-type="iso-abbrev">Ayu</journal-id><journal-id journal-id-type="publisher-id">AYU</journal-id><journal-title-group><journal-title>Ayu</journal-title></journal-title-group><issn pub-type="ppub">0974-8520</issn><issn pub-type="epub">0976-9382</issn><publisher><publisher-name>Medknow Publications &#x00026; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5041392</article-id><article-id pub-id-type="publisher-id">AYU-36-421</article-id><article-id pub-id-type="doi">10.4103/0974-8520.190697</article-id><article-categories><subj-group subj-group-type="heading"><subject>Pharmacological Study</subject></subj-group></article-categories><title-group><article-title><italic>In vitro</italic> thrombolytic activity of <italic>Dhamasa</italic> (<italic>Fagonia arabica</italic> Linn.), <italic>Kushta</italic> (<italic>Saussurea lappa</italic> Decne.), and <italic>Guduchi</italic> (<italic>Tinospora cordifolia</italic> Thunb.)</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Chaudhary</surname><given-names>Shweta</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Godatwar</surname><given-names>Pawan Kumar</given-names></name><xref ref-type="aff" rid="aff2">1</xref><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><name><surname>Sharma</surname><given-names>Reetu</given-names></name><xref ref-type="aff" rid="aff2">1</xref></contrib></contrib-group><aff id="aff1">Lecturer, Department of Roga Nidana and Vikriti Vijnana, Aligarh Unani and Ayurvedic Medical College, Aligarh, UP, India</aff><aff id="aff2"><label>1</label>Department of Roga Nidana and Vikriti Vigyan, National Institute of Ayurveda, Jaipur, Rajasthan, India</aff><author-notes><corresp id="cor1"><bold>Address for correspondence:</bold> Dr. Pawan Kumar Godatwar, Department of Roga and Vikriti Vigyan, National Institute of Ayurveda, Madhav Vilas Palace, Amer Road, Jaipur - 302 002, Rajasthan, India. E-mail: <email xlink:href="gpawankumar@rediffmail.com">gpawankumar@rediffmail.com</email></corresp></author-notes><pub-date pub-type="ppub"><season>Oct-Dec</season><year>2015</year></pub-date><volume>36</volume><issue>4</issue><fpage>421</fpage><lpage>424</lpage><permissions><copyright-statement>Copyright: &#x000a9; AYU (An International Quarterly Journal of Research in Ayurveda)</copyright-statement><copyright-year>2015</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.</license-p></license></permissions><abstract><sec id="st1"><title>Introduction:</title><p>Thrombotic disorders are among the major fatal conditions affecting the society. Treatment modalities used for such disorders are either surgical interventions or use of drugs such as urokinase, streptokinase (SK), or tissue plasminogen activators to dissolve the blood clots. These modalities have their own limitations and side effects apart from being expensive. There is a need for safer and cost effective antithrombolytic agents.</p></sec><sec id="st2"><title>Aim:</title><p>To evaluate <italic>in vitro</italic> thrombolytic property of <italic>Dhamasa</italic> (<italic>Fagonia arabica</italic> Linn.), <italic>Kushta</italic> (<italic>Saussurea lappa</italic> Decne.), and <italic>Guduchi</italic> (<italic>Tinospora cordifolia</italic> Thunb.) plant extract.</p></sec><sec id="st3"><title>Materials and Methods:</title><p>Venous blood drawn from 20 healthy volunteers was allowed to form clots which was weighed and treated with the extract of test plant materials to disrupt the clots. Weight of clot after and before treatment provided a percentage of clot lysis. SK was used as a positive and water as a negative control.</p></sec><sec id="st4"><title>Statistical Analysis Used:</title><p>The significance between % clot lysis of five groups by means of weight difference was tested by the one-way ANOVA.</p></sec><sec id="st5"><title>Results:</title><p>Clot lysis observed were 68.06%, 14.85%, 25.01%, 92.54%, and 3.00% for <italic>Dhamasa</italic>, <italic>Kushta</italic>, <italic>Guduchi</italic>, SK, and distilled water, respectively.</p></sec><sec id="st6"><title>Conclusion:</title><p>Herbal extracts possess thrombolytic properties and lyse blood clots <italic>in vitro</italic>.</p></sec></abstract><kwd-group><kwd><italic>Dhamasa</italic></kwd><kwd><italic>Fagonia arabica</italic></kwd><kwd><italic>Guduchi</italic></kwd><kwd><italic>Kushta</italic></kwd><kwd><italic>Saussurea lappa</italic></kwd><kwd>streptokinase</kwd><kwd>thrombolytic activity</kwd><kwd><italic>Tinospora cordifolia</italic></kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title>Introduction</title><p>Thrombosis is defined as &#x0201c;hemostasis in the wrong place,&#x0201d; and is a major cause of morbidity and mortality. Arterial thrombosis is a common cause of myocardial infarction, ischemic stroke, and limb gangrene whereas venous thrombosis leads to deep vein thrombosis which can be complicated by the post thrombotic syndrome, and pulmonary embolism, chronic thrombo-embolism, pulmonary hypertension.[<xref rid="ref1" ref-type="bibr">1</xref>] Number of other condition that can arise according to the location of the thrombus and the organs affected. The major risk factors for such thrombotic disorders are acquired disorders of hyper-coagulation, others being the exogenous factors such as surgery, hospitalization, immobility, trauma, pregnancy and the puerperium, and endogenous factors such as cancer, obesity.[<xref rid="ref2" ref-type="bibr">2</xref>]</p><p>Current treatment modalities of thrombotic disorders include surgical interventions or use of drugs such as alteplase, anistreplase, streptokinase (SK), urokinase, and tissue plasminogen activators.[<xref rid="ref3" ref-type="bibr">3</xref>] These modalities are costly as well as have serious side-effects which may be life threatening such as intracranial haemorrhage,[<xref rid="ref4" ref-type="bibr">4</xref>] spontaneous pulmonary haemorrhage,[<xref rid="ref5" ref-type="bibr">5</xref>] and angioedema.[<xref rid="ref6" ref-type="bibr">6</xref>] Moreover, these drugs are not used in patients who have undergone surgery or those with a history of nervous lesions, gastrointestinal bleeding, or hypertension.[<xref rid="ref7" ref-type="bibr">7</xref>] There is a need for safer and cost effective anti-thrombolytic agents. In order to find the blood thinning agents this work was conceived as it is known that herbal products are often perceived as safe because they are &#x0201c;natural.&#x0201d;[<xref rid="ref8" ref-type="bibr">8</xref>] This study aims to investigate the multiple solvent extracts of the three medicinal plants viz., <italic>Dhamasa</italic> (<italic>Fagonia arabica</italic> Linn.), <italic>Kushta</italic> (<italic>Saussurea lappa</italic> Decne.), and <italic>Guduchi</italic> (<italic>Tinospora cordifolia</italic> Thunb.) for their clot lysis (thrombolytic activity) by using thrombolytic <italic>in vitro</italic> model.</p></sec><sec sec-type="materials|methods" id="sec1-2"><title>Materials and Methods</title><p>The whole dry plant of <italic>Dhamasa</italic>, dry bark of <italic>Kushta</italic>, and dry stem of <italic>Guduchi</italic> were collected from the local market and were identified and authenticated by experts of the Department of Dravyaguna, National Institute of Ayurveda, Jaipur. The plants were cleaned, powdered and dried up in the hot air oven to remove the moisture content. The multiple solvent (methanol: Isopropyl alcohol: Acetone 100 ml each) extraction procedure was used to prepare extract by using Soxhlet apparatus. The extract was dried in the hot air oven and weighed to find out the percentage of extract formed from the dried powder.</p><p>About 100 mg of the extract thus formed was suspended in 10 ml distilled water (DW) and the suspension was shaken vigorously on a vortex mixer. The suspension was kept overnight and decanted to remove the soluble supernatant. Supernatant was filtered through a 0.22 &#x000b5; syringe filter and was used to check clot lysis. An <italic>in vitro</italic> thrombolytic model was used to check the clot lysing effect of aforesaid three plants. SK was used as a positive control and DW as a negative control.</p><sec id="sec2-1"><title>Clot lysis</title><p>Experiment for clot lysis was carried as reported earlier.[<xref rid="ref9" ref-type="bibr">9</xref>] In brief, 2.5 ml venous blood drawn from healthy volunteers was distributed in five different pre-weighed sterile micro-centrifuge tubes (0.5 ml/tube) and incubated at 37&#x000b0;C for 45 min. After clot formation, serum was completely removed (aspirated out without disturbing the clot formed) and each tube having clot was again weighed to determine the clot weight (clot weight = weight of clot containing tube &#x02212; weight of tube alone).</p><p>As a standard control, 100 &#x003bc;l of SK and as a non-thrombolytic control, 100 &#x003bc;l of DW along with 100 &#x003bc;l of each samples were separately added to the micro-centrifuge tubes. All the tubes were then incubated at 37&#x000b0;C for 90 min and observed for clot lysis. After incubation, fluid released was removed and tubes were again weighed to observe the difference in weight after clot disruption. Difference obtained in weight taken before and after clot lysis was expressed as percentage of clot lysis. The experiment was repeated 20 times with the blood samples of 20 volunteers.</p></sec><sec id="sec2-2"><title>Statistical analysis</title><p>Data are expressed as mean &#x000b1; standard error of the mean. The significance between % clot lysis by SK, DW, test plants by means of weight difference was tested by the one-way ANOVA by using Instat GraphPad version 5.01 (GraphPad Software, Inc., La Jolla, CA, USA).</p></sec></sec><sec sec-type="results" id="sec1-3"><title>Results</title><p>Addition of 100 &#x003bc;l SK, the standard control to the clots along with 90 min of incubation at 37&#x000b0;C, showed 92.54% &#x000b1;1.25% clot lysis. Clots when treated with 100 &#x003bc;l sterile DW (negative control) showed only negligible clot lysis (3.00% &#x000b1;0.597%). The mean difference in clot lysis percentage between positive and negative control was very significant (<italic>P</italic> &#x0003c; 0.001). After treatment of clots with 100 &#x003bc;l of <italic>Dhamasa</italic> (<italic>F. arabica</italic>), <italic>Guduchi</italic> (<italic>T. cordifolia</italic>), <italic>Kushta</italic> (<italic>S. lappa</italic>) clot lysis, i.e. 68.06% &#x000b1;3.53%, 25.01% &#x000b1;2.11%, 14.85% &#x000b1;1.37%, respectively, was obtained. When compared with the negative control (water) the mean clot lysis % difference of <italic>Dhamasa</italic> and <italic>Guduchi</italic> was significant (<italic>P</italic> &#x0003c; 0.001 in both) but mean clot lysis % difference of <italic>Kushta</italic> was not found to be significant (<italic>P</italic> &#x0003c; 0.01). When compared with the positive control (SK) the mean clot lysis % difference of all the three test plants was significant (<italic>P</italic> &#x0003c; 0.001 in all). Statistical representation of the effective clot lysis percentage by test plants, positive thrombolytic control (SK), and negative control (sterile DW) is tabulated in <xref ref-type="table" rid="T1">Table 1</xref>. Between group comparisons of percentage clot lysis is tabulated in <xref ref-type="table" rid="T2">Table 2</xref>.</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Thrombolytic activity of test drugs</p></caption><graphic xlink:href="AYU-36-421-g001"/></table-wrap><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Between group comparisons of percentage clot lysis</p></caption><graphic xlink:href="AYU-36-421-g002"/></table-wrap></sec><sec sec-type="discussion" id="sec1-4"><title>Discussion</title><p>In earlier study, thrombolytic effect of <italic>Dhamasa</italic> has been reported so it was selected to confirm the reported findings.[<xref rid="ref10" ref-type="bibr">10</xref>] <italic>Guduchi</italic> has been mentioned as best in &#x0201c;<italic>Shonitavibandhprashmana</italic>&#x0201d; (one that removes obstruction in blood) in <italic>Agrya Prakarana</italic> by <italic>Acharya Charaka</italic>.[<xref rid="ref11" ref-type="bibr">11</xref>] <italic>Kushta</italic> has been mentioned by <italic>Sushruta</italic> during description of <italic>Rakta mokshana</italic> (blood-letting). <italic>Sushruta</italic> says that in the process of <italic>Rakta mokshana</italic> if the bleeding does not occur due to clot formation then area should be rubbed by the powdered form of some drugs. <italic>Kushta</italic> is one among the drug mentioned to facilitate bloodletting.[<xref rid="ref12" ref-type="bibr">12</xref>] Textual references suggest that <italic>Guduchi</italic> and <italic>Kushta</italic> have thrombolytic property and so they were screened for their thrombolytic activity in the present study.</p><p>Herbal preparations are used since ancient times to maintain health and to prevent and treat various ailments. Advancement in field of phytochemistry have paved path for identification and isolation of plant compounds for curing diseases. Presently, about 30% of the pharmaceuticals are prepared from plants worldwide.[<xref rid="ref13" ref-type="bibr">13</xref>] Researches are going on extensively to find new alternative herbal drugs in various areas. Treatment of hyper coagulable state still remain a great challenge and to combat vascular diseases number of studies have been conducted by various researchers to find out the herbs and natural food sources and their supplements having antithrombotic effect.[<xref rid="ref7" ref-type="bibr">7</xref><xref rid="ref9" ref-type="bibr">9</xref><xref rid="ref13" ref-type="bibr">13</xref>] SK is a widely used thrombolytic drug by the modern science but it can cause serious and life threatening side effects.[<xref rid="ref14" ref-type="bibr">14</xref>] SK has its own complications like, bleeding which may be fatal with intracranial haemorrhage, it is also ineffective in individuals with anti-streptococcal and anti-prothrombin antibodies, and in patients who had multiple SK injections.[<xref rid="ref15" ref-type="bibr">15</xref><xref rid="ref16" ref-type="bibr">16</xref>] All available thrombolytic agents still have significant shortcomings, including the need for large doses to be maximally effective, limited fibrin specificity and bleeding tendency.</p><p>Coagulation factor or natural anticoagulant factor levels influence the risk of venous thrombosis along with other risk factors such as ageing, obesity, protein C deficiency, etc. Oxidative stress, which is defined as an imbalance between pro-oxidant and antioxidant systems, can be both a cause and consequence of many vascular complications and serve as one of the biomarkers for these conditions.[<xref rid="ref17" ref-type="bibr">17</xref>] <italic>F. arabica</italic> has been found to be beneficial in reducing oxidative stress by virtue of its antioxidant potential.[<xref rid="ref18" ref-type="bibr">18</xref>] Different parts of <italic>F. arabica</italic> have also been used to cure various ailments, namely hematological, neurological, endocrinological, and inflammatory disorders.[<xref rid="ref19" ref-type="bibr">19</xref>] <italic>T. cordifolia</italic>[<xref rid="ref20" ref-type="bibr">20</xref>] and <italic>Saussurea lappa</italic> are also found to have good anti-oxidant activity.[<xref rid="ref21" ref-type="bibr">21</xref>] These plants have properties which can help in preventing vascular diseases. The results of this study shows mild to moderate thrombolytic activity of test plants and so it gives an opportunity to explore their use in field of hypercoagulable state. These plants have <italic>Tikta</italic>/<italic>Katu</italic> (bitter/pungent) predominant <italic>Rasa</italic> (taste) and <italic>Ushna Virya</italic> (hot potency). <italic>Katu Rasa</italic> has property of &#x0201c;<italic>Shonitasanghata Bhinnati</italic>&#x0201d; (dissociates blood clots).[<xref rid="ref22" ref-type="bibr">22</xref>] <italic>Tikta Rasa</italic> has <italic>Lekhana</italic> and <italic>Kleda</italic>, <italic>Meda</italic>, <italic>Shleshma Upshoshana</italic> properties which may help in lysis of formed thrombus in blood vessels.[<xref rid="ref23" ref-type="bibr">23</xref>] It may be hypothesized that thrombolytic activity of these drugs might be due to above mentioned properties. In earlier studies also herbal medicines such as <italic>Hemidesmus indicus</italic> (L.) R. Br.,[<xref rid="ref24" ref-type="bibr">24</xref>] <italic>Allium sativum</italic> L.,[<xref rid="ref25" ref-type="bibr">25</xref>] <italic>Zingiber officinale</italic> Roscoe.,[<xref rid="ref26" ref-type="bibr">26</xref>] <italic>Ocimum sanctum</italic> L., <italic>Curcuma longa</italic> L., and <italic>Azadirachta indica</italic> A. Juss[<xref rid="ref27" ref-type="bibr">27</xref>] have been shown to exert thrombolytic or fibrinolytic effects. Positive results give hope to develop drugs in future but there is need of extensive research to find out active constituents so that development of alternative novel thrombolytic drugs can be done.</p></sec><sec sec-type="conclusion" id="sec1-5"><title>Conclusion</title><p><italic>Dhamasa</italic> showed a significant percentage of clot lysis which is comparable with SK, a well-known thrombolytic drug. <italic>Guduchi</italic> and <italic>Kushta</italic> also showed mild thrombolytic activity. This study indicates possibility of finding novel thrombolytic drugs. However, there is need of thorough phytochemical and pharmacological research to discover their therapeutic potential. Once proved on scientific grounds these herbal preparations may be incorporated as thrombolytic agent for the improvement of the patients suffering from atherothrombotic diseases.</p><sec id="sec2-3"><title>Financial support and sponsorship</title><p>National Institute of Ayurveda, Jaipur, Rajasthan, India.</p></sec><sec id="sec2-4"><title>Conflicts of interest</title><p>There are no conflicts of interest.</p></sec></sec></body><back><ref-list><ref id="ref1"><label>1</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Freedman</surname><given-names>JE</given-names></name><name><surname>Loscalzo</surname><given-names>J</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Dennis Kasper</surname></name><name><surname>Anthony Fauci</surname></name><name><surname>Stephen Hauser</surname></name><name><surname>Dan Longo</surname></name><name><surname>J. Larry</surname><given-names>Jameson</given-names></name><name><surname>Joseph Loscalzo</surname></name></person-group><article-title>Arterial and venous thrombosis</article-title><source>Harrison's Principles of Internal Medicine</source><date-in-citation>Last accessed on 2016 Feb. 01</date-in-citation><edition>19th ed</edition><issue>Ch. 142</issue><publisher-name>McGraw Hill</publisher-name><comment>Available from: <uri xlink:type="simple" xlink:href="http://www.accessmedicine.mhmedical.com/content.aspx?bookid=331andsectionid=40726857">http://www.accessmedicine.mhmedical.com/content.aspx?bookid=331 and sectionid=40726857</uri></comment></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cushman</surname><given-names>M</given-names></name></person-group><article-title>Epidemiology and risk factors for venous thrombosis</article-title><source>Semin Hematol</source><year>2007</year><volume>44</volume><fpage>62</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">17433897</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collen</surname><given-names>D</given-names></name></person-group><article-title>Coronary thrombolysis: Streptokinase or recombinant tissue-type plasminogen activator?</article-title><source>Ann Intern Med</source><year>1990</year><volume>112</volume><fpage>529</fpage><lpage>38</lpage><pub-id pub-id-type="pmid">2107781</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rouf</surname><given-names>SA</given-names></name><name><surname>Moo-Young</surname><given-names>M</given-names></name><name><surname>Chisti</surname><given-names>Y</given-names></name></person-group><article-title>Tissue-type plasminogen activator: Characteristics, applications and production technology</article-title><source>Biotechnol Adv</source><year>1996</year><volume>14</volume><fpage>239</fpage><lpage>66</lpage><pub-id pub-id-type="pmid">14537155</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Awadh</surname><given-names>N</given-names></name><name><surname>Ronco</surname><given-names>JJ</given-names></name><name><surname>Bernstein</surname><given-names>V</given-names></name><name><surname>Gilks</surname><given-names>B</given-names></name><name><surname>Wilcox</surname><given-names>P</given-names></name></person-group><article-title>Spontaneous pulmonary hemorrhage after thrombolytic therapy for acute myocardial infarction</article-title><source>Chest</source><year>1994</year><volume>106</volume><fpage>1622</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">7956438</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>JP</given-names></name><name><surname>Quarry</surname><given-names>DP</given-names></name><name><surname>Beale</surname><given-names>DJ</given-names></name><name><surname>Chappell</surname><given-names>AG</given-names></name></person-group><article-title>Life-threatening, localized angio-oedema associated with streptokinase</article-title><source>Postgrad Med J</source><year>1994</year><volume>70</volume><fpage>592</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">7937456</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naderi</surname><given-names>GA</given-names></name><name><surname>Asgary</surname><given-names>S</given-names></name><name><surname>Jafarian</surname><given-names>A</given-names></name><name><surname>Askari</surname><given-names>N</given-names></name><name><surname>Behagh</surname><given-names>A</given-names></name><name><surname>Aghdam</surname><given-names>RH</given-names></name></person-group><article-title>Fibrinolytic effects of Ginkgo biloba extract</article-title><source>Exp Clin Cardiol</source><year>2005</year><volume>10</volume><fpage>85</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">19641664</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Demrow</surname><given-names>HS</given-names></name><name><surname>Slane</surname><given-names>PR</given-names></name><name><surname>Folts</surname><given-names>JD</given-names></name></person-group><article-title>Administration of wine and grape juice inhibits <italic>in vivo</italic> platelet activity and thrombosis in stenosed canine coronary arteries</article-title><source>Circulation</source><year>1995</year><volume>91</volume><fpage>1182</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">7850957</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prasad</surname><given-names>S</given-names></name><name><surname>Kashyap</surname><given-names>RS</given-names></name><name><surname>Deopujari</surname><given-names>JY</given-names></name><name><surname>Purohit</surname><given-names>HJ</given-names></name><name><surname>Taori</surname><given-names>GM</given-names></name><name><surname>Daginawala</surname><given-names>HF</given-names></name></person-group><article-title>Development of an <italic>in vitro</italic> model to study clot lysis activity of thrombolytic drugs</article-title><source>Thromb J</source><year>2006</year><volume>4</volume><fpage>14</fpage><pub-id pub-id-type="pmid">16968529</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prasad</surname><given-names>S</given-names></name><name><surname>Kashyap</surname><given-names>RS</given-names></name><name><surname>Deopujari</surname><given-names>JY</given-names></name><name><surname>Purohit</surname><given-names>HJ</given-names></name><name><surname>Taori</surname><given-names>GM</given-names></name><name><surname>Daginawala</surname><given-names>HF</given-names></name></person-group><article-title>Effect of <italic>Fagonia arabica</italic> (<italic>Dhamasa</italic>) on <italic>in vitro</italic> thrombolysis</article-title><source>BMC Complement Altern Med</source><year>2007</year><volume>7</volume><fpage>36</fpage><pub-id pub-id-type="pmid">17986325</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Shastri</surname><given-names>K</given-names></name><name><surname>Chaturvedi</surname><given-names>GN</given-names></name></person-group><source>Commentator. Charaka Samhita of Agnivesha, Sutra Sthana</source><year>468</year><edition>1st ed (Reprint)</edition><issue>Ch. 25, Ver. 40</issue><publisher-loc>Varanasi</publisher-loc><publisher-name>Chaukhambha Bharati Academy</publisher-name></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Acharya</surname><given-names>JT</given-names></name></person-group><source>Sushruta Samhita of Sushruta, Sutra Sthana</source><year>2008</year><edition>1st ed</edition><issue>Ch. 14, Ver. 35</issue><publisher-loc>Varanasi</publisher-loc><publisher-name>Chaukhamba Surbharati Prakashan</publisher-name><fpage>65</fpage></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Anwar</surname><given-names>AK</given-names></name><name><surname>Ashfaq</surname><given-names>M</given-names></name><name><surname>Nasveen</surname><given-names>MA</given-names></name></person-group><source>Pharmacognostic studies of selected indigenous plants of Pakistan</source><year>1979</year><publisher-loc>Pakistan</publisher-loc><publisher-name>Pakistan Forest Institute, Peshawar NWFP</publisher-name><fpage>15</fpage><lpage>35</lpage></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheehan</surname><given-names>FH</given-names></name><name><surname>Braunwald</surname><given-names>E</given-names></name><name><surname>Canner</surname><given-names>P</given-names></name><name><surname>Dodge</surname><given-names>HT</given-names></name><name><surname>Gore</surname><given-names>J</given-names></name><name><surname>Van Natta</surname><given-names>P</given-names></name><etal/></person-group><article-title>The effect of intravenous thrombolytic therapy on left ventricular function: A report on tissue-type plasminogen activator and streptokinase from the thrombolysis in myocardial infarction (TIMI phase I) trial</article-title><source>Circulation</source><year>1987</year><volume>75</volume><fpage>817</fpage><lpage>29</lpage><pub-id pub-id-type="pmid">3103950</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buchalter</surname><given-names>MB</given-names></name><name><surname>Suntharalingam</surname><given-names>G</given-names></name><name><surname>Jennings</surname><given-names>I</given-names></name><name><surname>Hart</surname><given-names>C</given-names></name><name><surname>Luddington</surname><given-names>RJ</given-names></name><name><surname>Chakraverty</surname><given-names>R</given-names></name><etal/></person-group><article-title>Streptokinase resistance: When might streptokinase administration be ineffective?</article-title><source>Br Heart J</source><year>1992</year><volume>68</volume><fpage>449</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">1467027</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puurunen</surname><given-names>M</given-names></name><name><surname>M&#x000e4;ntt&#x000e4;ri</surname><given-names>M</given-names></name><name><surname>Manninen</surname><given-names>V</given-names></name><name><surname>Palosuo</surname><given-names>T</given-names></name><name><surname>Vaarala</surname><given-names>O</given-names></name></person-group><article-title>Antibodies to prothrombin crossreact with plasminogen in patients developing myocardial infarction</article-title><source>Br J Haematol</source><year>1998</year><volume>100</volume><fpage>374</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">9488629</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>YW</given-names></name><name><surname>Byzova</surname><given-names>TV</given-names></name></person-group><article-title>Oxidative stress in angiogenesis and vascular disease</article-title><source>Blood</source><year>2014</year><volume>123</volume><fpage>625</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">24300855</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Satpute</surname><given-names>R</given-names></name><name><surname>Bhattacharya</surname><given-names>R</given-names></name><name><surname>S Kashyap</surname><given-names>R</given-names></name><name><surname>J Purohit</surname><given-names>H</given-names></name><name><surname>Y Deopujari</surname><given-names>J</given-names></name><name><surname>M Taori</surname><given-names>G</given-names></name><etal/></person-group><article-title>Antioxidant Potential of <italic>Fagonia arabica</italic> against the chemical ischemia-induced in PC12 cells</article-title><source>Iran J Pharm Res</source><year>2012</year><volume>11</volume><fpage>303</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">24250453</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Chopra</surname><given-names>RM</given-names></name><name><surname>Handa</surname><given-names>KL</given-names></name><name><surname>Kapur</surname><given-names>LD</given-names></name><name><surname>Chopra</surname><given-names>IC</given-names></name></person-group><source>Indigenous Drugs of India</source><year>1982</year><edition>2nd ed</edition><publisher-loc>New Delhi</publisher-loc><publisher-name>Academic Publisher</publisher-name><fpage>507</fpage></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goel</surname><given-names>HC</given-names></name><name><surname>Prem Kumar</surname><given-names>I</given-names></name><name><surname>Rana</surname><given-names>SV</given-names></name></person-group><article-title>Free radical scavenging and metal chelation by <italic>Tinospora cordifolia</italic>, a possible role in radioprotection</article-title><source>Indian J Exp Biol</source><year>2002</year><volume>40</volume><fpage>727</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">12587720</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saha</surname><given-names>AK</given-names><suffix>Md</suffix></name><name><surname>Rahman</surname><given-names>R</given-names></name><name><surname>Shahriar</surname><given-names>M</given-names></name><name><surname>Saha</surname><given-names>SK</given-names></name><name><surname>Azad</surname><given-names>NA</given-names></name><name><surname>Das</surname><given-names>S</given-names></name></person-group><article-title>Screening of six ayurvedic medicinal plant extracts for antioxidant and cytotoxic activity</article-title><source>J Pharmacogn Phytochem</source><year>2013</year><volume>2</volume><fpage>181</fpage><lpage>8</lpage></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Acharya</surname><given-names>YT</given-names></name></person-group><source>Charaka Samhita of Agnivesha, Sutra Sthana</source><year>2011</year><edition>1st ed (Reprint)</edition><issue>Ch. 26, Ver. 424</issue><publisher-loc>Varanasi</publisher-loc><publisher-name>Chaukhambha Subharati Prakashana</publisher-name><fpage>144</fpage></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Acharya</surname><given-names>YT</given-names></name></person-group><source>Charaka Samhita of Agnivesha, Sutra Sthana</source><year>2011</year><edition>1st ed (Reprint)</edition><issue>Ch. 26, Ver. 425</issue><publisher-loc>Varanasi</publisher-loc><publisher-name>Chaukhambha Subharati Prakashana</publisher-name><fpage>144</fpage></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mary</surname><given-names>NK</given-names></name><name><surname>Achuthan</surname><given-names>CR</given-names></name><name><surname>Babu</surname><given-names>BH</given-names></name><name><surname>Padikkala</surname><given-names>J</given-names></name></person-group><article-title><italic>In vitro</italic> antioxidant and antithrombotic activity of <italic>Hemidesmus indicus</italic> (L) R.Br</article-title><source>J Ethnopharmacol</source><year>2003</year><volume>87</volume><fpage>187</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">12860306</pub-id></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bordia</surname><given-names>A</given-names></name><name><surname>Verma</surname><given-names>SK</given-names></name><name><surname>Srivastava</surname><given-names>KC</given-names></name></person-group><article-title>Effect of garlic (<italic>Allium sativum</italic>) on blood lipids, blood sugar, fibrinogen and fibrinolytic activity in patients with coronary artery disease</article-title><source>Prostaglandins Leukot Essent Fatty Acids</source><year>1998</year><volume>58</volume><fpage>257</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">9654398</pub-id></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verma</surname><given-names>SK</given-names></name><name><surname>Bordia</surname><given-names>A</given-names></name></person-group><article-title>Ginger, fat and fibrinolysis</article-title><source>Indian J Med Sci</source><year>2001</year><volume>55</volume><fpage>83</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">11482162</pub-id></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>IN</given-names></name><name><surname>Habib</surname><given-names>MR</given-names></name><name><surname>Rahman</surname><given-names>MM</given-names></name><name><surname>Mannan</surname><given-names>A</given-names></name><name><surname>Sarker</surname><given-names>MM</given-names></name><name><surname>Hawlader</surname><given-names>S</given-names></name></person-group><article-title>Thrombolytic potential of <italic>Ocimum sanctum</italic> L. <italic>Curcuma longa</italic> L. <italic>Azadirachta indica</italic> L. and <italic>Anacardium occidentale</italic> L</article-title><source>J Basic Clin Pharm</source><year>2011</year><volume>2</volume><fpage>125</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">24826011</pub-id></element-citation></ref></ref-list></back></article>